In this study, involvement of peripheral AMPA receptors in mediating craniofacial muscle pain was investigated. AMPA receptor subunits, GluR1 and GluR2, were predominantly expressed in small to medium size neurons but more GluR2 positive labeling were encountered in trigeminal ganglia (TG) of male Sprague Dawley rats. A greater prevalence of GluR2 is reflected by the significantly higher percentage of GluR2 than GluR1 positive masseter afferents. Nocifensive behavior and c-fos immunoreactivity were assessed from the same animals that received intramuscular mustard oil (MO) with or without NBQX, a potent AMPA/KA receptor antagonist. Masseteric MO produced nocifensive hindpaw shaking responses that peaked in the first 30 s and gradually diminished over a few minutes. There was a significant difference in both peak and overall MO-induced nocifensive responses between NBQX and vehicle pre-treated rats. Subsequent Fos studies also showed that peripheral NBQX pre-treatment effectively reduced the MO-induced neuronal activation in the subnucleus caudalis of the trigeminal nerve (Vc). These combined results provide compelling evidence that acute muscle nociception is mediated, in part, by peripherally located AMPA/KA receptors, and that blockade of multiple peripheral glutamate receptor subtypes may provide a more effective means of reducing muscular pain and central neuronal activation. #
Introduction
Glutamate receptors located on peripheral terminals of nociceptors are activated by glutamate released from various sources such as neurons, Schwan cells, and macrophages, following injury or inflammation (Piani et al., 1991; Parpura et al., 1995; deGroot et al., 2000; Lawand et al., 2000) . Glutamate administered directly to the masseter muscle activates and sensitizes nociceptors in rats and produces pain in human subjects via peripheral NMDA receptors (Cairns et al., 2003 (Cairns et al., , 2006 . Blockade of peripheral NMDA receptors significantly reduces mustard oil (MO)-and hypertonic saline-induced nocifensive behaviors, edema formation in the masseter, and c-fos activation in the caudal subnucleus of the spinal trigeminal nucleus (Vc), a major nociceptive processing area for orofacial input (Ro, 2003; Ro et al., 2004 Ro et al., , 2007 .
Similarly, local administration of an mGluR5, but not mGluR1, antagonist effectively reduces the MO-induced nocifensive behavior and plasma extravasation in the rat masseter (Lee et al., 2006) . Consistent with this observation, 3,5-dihydroxyphenylglycol (DHPG), a group I mGluR agonist, mediated masseter hypersensitivity is significantly attenuated when an mGluR5 antagonist is co-administered (Lee and Ro, 2007a) . These data strongly suggest that peripheral mGluR and NMDA receptors are involved in localized muscle pain, mechanical hypersensitivity and inflammation.
While it is likely that AMPA/KA receptors could also contribute to muscle nociception, relative involvement of peripheral AMPA/KA receptors in muscle nociception are yet to be elucidated. This is an important gap to fill since peripherally released glutamate will obviously activate all subtypes of glutamate receptors. This study investigates whether AMPA 
